Adiponectin: An Endothelium-Derived Vasoprotective Factor?

Author(s): Lei Shen, Ian M. Evans, Domingos Souza, Mats Dreifaldt, Michael R. Dashwood, Mohamed-Ali Vidya.

Journal Name: Current Vascular Pharmacology

Volume 14 , Issue 2 , 2016

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Adipose tissue (AT) is now widely accepted as a key secretary organ, as well as an energy storage depot. It secretes a series of cytokines, hormones and bioactive molecules: adipokines. Adiponectin is an abundant systemic adipokine that uniquely is reduced in obesity and increases on weight loss, is anti-inflammatory, promotes insulin sensitivity and affords cardiometabolic protection. It was considered a true adipokine, in that it is exclusively generated by the adipocytes of the adipose tissue. However, recent evidence points to it being secreted by a range of other organs. This review summarizes the non-adipose sources of adiponectin especially that derived from the endothelium, its vasoprotective role and intracellular signalling pathways. Endothelium derived adiponectin may potentially be a new target for clinical intervention in cardiovascular disease.

Keywords: Adiponectin, coronary artery bypass grafting, endothelium, perivascular adipose tissue.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 14
ISSUE: 2
Year: 2016
Page: [168 - 174]
Pages: 7
DOI: 10.2174/1570161114666151202210128
Price: $58

Article Metrics

PDF: 20
HTML: 1
EPUB: 1
PRC: 1